Type
Business expansion
Country
Germany
Region
Mecklenburg-Vorpommern; Schwerin; Kreisfreie Stadt
Location of affected unit(s)
Schwerin
Sector
Manufacturing
Manufacturing Of Furniture And Other Manufacturing
Other Manufacturing
32.5 - Manufacture Of Medical And Dental Instruments And Supplies

735 jobs
Number of planned job creations
Job creation
Announcement Date
17 October 2024
Employment effect (start)
15 October 2024
Foreseen end date

Description

As announced on 17 October 2024, the Swiss medical technology company Ypsomed has opened a new production hall in Schwerin. The company specializes in injection and infusion systems for self-medication. The company invested 22 million Swiss francs in the facility. This expansion of production capacity is in response to the growing global demand for high-quality medical technology products. In the future, the production hall is expected to be further expanded, creating around 650 new jobs and 35 new apprenticeships. So far, 85 new positions have already been created in Schwerin. Ypsomed currently employs 2,400 people worldwide.


Sources

Citation

Eurofound (2024), Ypsomed, Business expansion in Germany, factsheet number 201798, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201798.